Does remnants from low-risk differentiated thyroid cancer patients really be not treated with Iodine-131?

被引：0
|
作者：
Barbato, F. [1 ]
Capacchione, D. [1 ]
Nappi, A. [1 ]
Telesca, D. [1 ]
Tempone, A. [1 ]
Casolino, E. [1 ]
Nardelli, A. [2 ]
Castaldi, E. [2 ]
Ortosecco, G. [2 ]
Storto, G. [1 ]
机构：
[1] IRCCS CROB, Rionero In Vulture, Italy
[2] IBB CNR, Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S321 / S321
页数：1
相关论文
共 50 条
  • [1] Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation?
    D'Antuono, F.
    Gallicchio, R.
    Venetucci, A.
    Nardelli, A.
    Giacomobono, S.
    Pellegrino, T.
    Tempone, A.
    Di Leo, A.
    Gattozzi, D.
    Storto, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S126 - S126
  • [2] Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?
    Rosj Gallicchio
    Sabrina Giacomobono
    Daniela Capacchione
    Anna Nardelli
    Francesco Barbato
    Antonio Nappi
    Teresa Pellegrino
    Giovanni Storto
    Endocrine, 2013, 44 : 426 - 433
  • [3] Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?
    Gallicchio, Rosj
    Giacomobono, Sabrina
    Capacchione, Daniela
    Nardelli, Anna
    Barbato, Francesco
    Nappi, Antonio
    Pellegrino, Teresa
    Storto, Giovanni
    ENDOCRINE, 2013, 44 (02) : 426 - 433
  • [4] Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer
    Mandel, SJ
    Shankar, LK
    Benard, F
    Yamamoto, A
    Alavi, A
    CLINICAL NUCLEAR MEDICINE, 2001, 26 (01) : 6 - 9
  • [5] Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer
    Caglar, Meltem
    Bozkurt, Fani M.
    Akca, Ceren Kapulu
    Vargol, Sezen Elhan
    Bayraktar, Miyase
    Ugur, Omer
    Karaagaoglu, Ergun
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (03) : 268 - 274
  • [6] Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma
    MKacher, R
    Legal, JD
    Schlumberger, M
    Voisin, P
    Aubert, B
    Gaillard, N
    Parmentier, C
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (11) : 1860 - 1864
  • [7] Evaluation of ablation of thyroid remnants with 1850MBq iodine-131 in patients with thyroid cancer
    Kawabe, J.
    Higashiyama, S.
    Kotani, K.
    Yoshida, A.
    Shiomi, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S730 - S731
  • [8] Evaluation of ablation of thyroid remnants with 1850 MBq iodine-131 in 67 patients with thyroid cancer
    Kawabe, Joji
    Higashiyama, Shigeaki
    Kotani, Kohei
    Yoshida, Atsushi
    Onoda, Naoyoshi
    Shiomi, Susumu
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (01): : 68 - 75
  • [9] Comparison of 1.1 gbq and 2.2 gbq131I activities in patients with low-risk differentiated thyroid cancer requiring postoperative iodine-131 therapy.
    Campenni, A.
    Ruggeri, R.
    Garo, M.
    Raffa, A.
    Siracusa, M.
    Restuccia, G.
    Rappazzo, A.
    Rosarno, H.
    Nicocia, A.
    Cardile, D.
    Ovcaricek, P. Petranovic
    Baldari, S.
    Giovanella, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S171 - S172
  • [10] Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma
    Leger, FA
    Izembart, M
    Dagousset, F
    Barritault, L
    Baillet, G
    Chevalier, A
    Clerc, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (03) : 242 - 246
12345